Cubist pharmaceuticals stock price
WebApr 11, 2024 · 3 Wall Street research analysts have issued 1-year price objectives for Amphastar Pharmaceuticals' shares. Their AMPH share price forecasts range from $36.00 to $44.00. On average, they predict the company's share price to reach $40.75 in the next year. This suggests a possible upside of 3.2% from the stock's current price. WebDec 8, 2014 · Cubist Pharmaceuticals, Inc. (NASDAQ:CBST) today announced that the companies have entered into a definitive agreement under which Merck will acquire …
Cubist pharmaceuticals stock price
Did you know?
WebCubist Pharmaceuticals Inc. share price - Stocktwits is the best way to find out what is happening right now around the CBST stock and other stock companies and markets. WebApr 6, 2024 · Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) issued its quarterly earnings results on Tuesday, February, 28th. The company reported $0.06 EPS for the quarter, topping the consensus estimate of ($0.24) by $0.30. The company had revenue of $61.88 million for the quarter, compared to analysts' expectations of $47.18 million.
WebMar 7, 2011 · Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that its Board of Directors has appointed Kenneth M. (Ken) Bate as non-executive Chair of the Board effective immediately. Mr. Bate has been serving as Lead Director of the Cubist Board since June of 2006. Cubist has had a long-standing commitment to the clear … WebDec 8, 2014 · News of the deal sent Cubist's share price surging by more than 34 percent, to $101.15, in premarket trading. Merck's stock price also rose more than 5 percent.
WebApr 12, 2024 · Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT – Get Rating)’s stock price traded up 6.3% during mid-day trading on Tuesday after Piper Sandler raised their price target on the stock from $49.00 ... WebApr 10, 2024 · According to analysts' consensus price target of $45.17, Ionis Pharmaceuticals has a forecasted upside of 22.8% from its current price of $36.79. Amount of Analyst Coverage Ionis Pharmaceuticals has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock. See Top …
WebJul 14, 2024 · Cubist Pharmaceuticals Inc (NASDAQ:CBST) issued its earnings results on Tuesday, October, 21st. The biopharmaceutical company reported $0.58 earnings per … Their NVAX share price forecasts range from $27.00 to $168.00. On average, … What is Intercept Pharmaceuticals' stock price forecast for 2024? 7 equities … The current CBST price target is $0.00. Learn why top analysts are making this …
WebApr 14, 2024 · FaZe Holdings Inc. ( NASDAQ:FAZE – Get Rating )’s stock price shot up 6.3% on Thursday . The company traded as high as $0.52 and last traded at $0.51. 384,459 shares changed hands during ... floyd lee wiseman mims floridaWebExhibit 10.1 . CUBIST PHARMACEUTICALS, INC. 2014 OMNIBUS INCENTIVE PLAN . STOCK OPTION AGREEMENT. FOR DIRECTORS . This Stock Option Agreement (the “Agreement”) governs an award (the “Award”) of stock options (“Stock Options”) to non-employee members of the Board of Directors of Cubist Pharmaceuticals, Inc. (the … floyd lawton daughterWebDec 8, 2014 · NEW YORK -- Shares of Cubist Pharmaceuticals are up 36.01% to $101.14 in pre-market trade after it was reported that Merck & Co. greencross abnWebMar 20, 2014 · Cubist Pharmaceuticals and Durata Therapeutics both have antibiotics scheduled for regulatory review with the FDA later this month. Which company offers investors the better risk to reward profile? floyd landis bicycleWebNumber of Exits 1. Phone Number +8589090737. Optimer Pharmaceuticals, Inc. (Optimer) is a biopharmaceutical company focused on discovering, developing and commercializing anti-infective products. It has two late-stage anti-infective product candidates, fidaxomicin and Pruvel (prulifloxacin). Optimer's development efforts are focused on products ... floyd lee - mean bluesWebCBST (CBST) has the following price history information. Looking back at CBST historical stock prices for the last five trading days, on January 14, 2015, CBST opened at … green cross 500mlWebApr 12, 2024 · Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT – Get Rating) shot up 6.3% on Tuesday after Piper Sandler raised their price target on the stock from $49.00 to $54.00. Piper Sandler currently has ... green cross 3d